US Patent 9149470 Macrocyclic lactone compounds and methods for their use
Patent 9149470 was granted and assigned to Elixir Medical Corporation on October, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+164 characters)
Article
Patent abstract
The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the general formula:
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09149470 Macrocyclic lactone compounds and methods for their use US Patent 9149470 Macrocyclic lactone compounds and methods for their use
Infobox
Patent Number
091494700
Patent Number
91494700
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091494700
Date of Patent
October 6, 2015
0Patent Application Number
133025880
Date Filed
November 22, 2011
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09149470 Macrocyclic lactone compounds and methods for their use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09149470
Date of patent
October 6, 2015
Patent application number
13302588
Date Filed
November 22, 2011
Patent primary examiner
Find more entities like US Patent 9149470 Macrocyclic lactone compounds and methods for their use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.